The healthcare analytics industry in the DACH region focuses on optimizing patient care through data-driven insights. Companies range from startups developing predictive software to established firms offering data management platforms, all aiming to enhance decision-making in healthcare. With an emphasis on improving outcomes in areas like disease management and treatment efficacy, the industry is experiencing rapid innovation. Recent trends include the integration of artificial intelligence to analyze patient data and streamline processes. As the demand for personalized medicine escalates, the DACH region is becoming a hub for healthcare analytics investments, shaping the future of health technology.


The list of top healthcare analytics investors in the DACH region features a mix of venture capital firms and corporate investors, primarily based in Austria, Germany, and Switzerland. Ranging in size from small teams to those with over 10,000 employees, these firms were founded between 1979 and 2015. In total, they made an impressive 268 investments in 2024. Noteworthy players like Novartis and Mandap are commercializing innovative healthcare solutions while actively supporting burgeoning startups.


Top 16 Healthcare Analytics Investors in DACH


1. Speedinvest

  • Website: speedinvest.com
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2011
  • Headcount: 51-200
  • Number of deals in 2024: 45
  • LinkedIn: speedinvest

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help these startups scale their operations. Speedinvest's focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Notably, they have made significant investments in the healthcare analytics space, participating in funding rounds for companies like Elephant Healthcare, which raised $13.6 million in Series A, and Medicus AI, which secured $682,571 in an Angel Round. Additionally, they were involved in funding IOMED, a Barcelona-based medtech startup, which raised €2 million in a round aimed at expanding its operations. Most recently, Speedinvest participated in a Series B round for Doccla, which raised approximately $46 million. These transactions highlight Speedinvest's commitment to supporting innovative healthcare analytics solutions.


2. Novartis

  • Website: novartis.com
  • Type: Corporate
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 10001+
  • Number of deals in 2024: 7
  • LinkedIn: novartis

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company is dedicated to developing and manufacturing innovative medicines that address serious diseases across various therapeutic areas. Novartis emphasizes research and development to enhance patient outcomes globally. In recent years, Novartis has made significant investments in healthcare analytics, including a Series B investment in COTA Healthcare, which focuses on data analytics for oncology, and a $45 million Series B investment in Holmusk, a company that leverages data analytics to improve mental health outcomes. Additionally, they participated in the Seed Round for Patientory, which aims to improve healthcare data management. These transactions highlight Novartis's strategic interest in integrating healthcare analytics into their operations and supporting innovations that can transform patient care.


3. Bayern Kapital

  • Website: bayernkapital.de
  • Type: Venture Capital
  • Headquarters: Landshut, Bavaria, Germany
  • Founded year: 1995
  • Headcount: 11-50
  • Number of deals in 2024: 27
  • LinkedIn: bayern-kapital-gmbh

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria, particularly in sectors such as life sciences and software. In 2024, Bayern Kapital has been involved in 27 investments, showcasing their active role in the venture capital landscape. Among their notable transactions, they participated in funding rounds for healthtech companies like Ebenbuild, which is developing a lung simulation prototype for medical device approval, and Deepeye Medical, which focuses on AI-driven solutions for radiology diagnostics. Additionally, their investment in Ryver.AI highlights their interest in addressing bias in medical AI through diverse synthetic data, further emphasizing their commitment to healthcare analytics and innovation.


4. Novartis Venture Fund

  • Website: nvfund.com
  • Type: Venture Capital
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 11-50
  • Number of deals in 2024: 10

Novartis Venture Fund is a venture capital firm based in Basel, Switzerland, specializing in life sciences investments. Founded in 1996, the fund focuses on providing funding and support to innovative biotechnology and biopharmaceutical companies, helping them develop novel therapeutics and address unmet patient needs. The fund has been involved in several significant transactions, including investments in Flywheel.io, which raised $27 million in Series C funding to enhance its data management platform for biomedical research, highlighting the fund's interest in healthcare analytics. Additionally, they have invested in ImaginAb, a clinical-stage biotech company, which, while primarily focused on cancer therapeutics, also emphasizes the importance of data in its development processes. These transactions illustrate the fund's commitment to supporting advancements in healthcare through innovative technologies, including analytics.


5. Sictic

  • Website: sictic.ch
  • Type: Venture Capital
  • Headquarters: Zurich, Zurich, Switzerland
  • Founded year: 2014
  • Headcount: 201-500
  • Number of deals in 2024: 77
  • LinkedIn: sictic

SICTIC is a not-for-profit organization based in Zurich, Switzerland, that connects smart money investors with innovative Swiss early-stage technology startups. Founded in 2014, SICTIC provides investment opportunities, networking events, and educational resources to facilitate the growth of startups and the investment community. Notably, SICTIC has been involved in several transactions within the healthcare analytics space, including investments in Komed Health, which raised funds to develop a communication platform for healthcare, and PeriVision, a University of Bern spin-off focused on healthcare research and product development. These transactions highlight SICTIC's commitment to supporting healthcare innovation and analytics.


6. Verve Ventures

  • Website: verve.vc
  • Type: Venture Capital
  • Headquarters: Zurich, Zurich, Switzerland
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 25
  • LinkedIn: investiere-venture-capital

Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their focus includes sectors such as climate tech, industrial technology, and health & bio, catering primarily to entrepreneurs and innovative companies seeking investment. Notably, Verve Ventures has been involved in significant transactions in the healthcare analytics space, including investments in DomoHealth, which raised funds in multiple rounds (Seed, Angel, and Series A) for its health data management solutions. Additionally, they have invested in Retinai, which raised substantial amounts in Series A and Series B rounds, indicating a focus on advancing healthcare technology. These transactions highlight Verve Ventures' active role in the healthcare analytics industry.


7. Calm/Storm

  • Website: calmstorm.vc
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2020
  • Headcount: 1-10
  • Number of deals in 2024: 13
  • LinkedIn: calm-storm

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm specializes in early-stage investments in health tech startups, focusing on purpose-driven founders. Calm/Storm provides capital, support, and networking opportunities to help these companies succeed in the competitive health tech landscape. Their portfolio includes diverse teams addressing sensitive health issues. Notable transactions include investments in Thymia, a healthtech startup that raised funds to expand its AI-driven mental health platform, and Livv Health, which raised over $1.5 million in a pre-seed round. These investments highlight Calm/Storm's commitment to advancing healthcare analytics and technology.


8. HBM Healthcare Investments AG


HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in the healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. In 2021, HBM participated in significant funding rounds for companies like Freenome, which raised $300 million in Series D funding, and Valo Health, which raised $190 million in Series B and an undisclosed amount in Series C funding. Notably, they also invested in Genalyte, a diagnostics and analytics company, which highlights their focus on healthcare analytics. HBM Healthcare Investments aims to provide growth opportunities in the rapidly evolving healthcare market, making them a key player in the healthcare investment landscape.


9. b2venture

  • Website: b2venture.vc
  • Type: Venture Capital
  • Headquarters: St. Gallen, St. Gallen, Switzerland
  • Founded year: 2000
  • Headcount: 11-50
  • Number of deals in 2024: 15
  • LinkedIn: btovpartners

b2venture is a venture capital firm based in St. Gallen, Switzerland, specializing in early-stage investments across various sectors. Founded in 2000, the firm has established itself as a key player in the European venture capital landscape, providing financial backing and support to innovative startups. In recent years, b2venture has been involved in several notable transactions within the healthcare analytics space. For instance, they participated in the Series A funding round for LynxCare, a company focused on healthcare data management, which raised €20M to accelerate its international rollout. Additionally, they were involved in the funding of Vamstar, a London-based provider of an AI-enabled procurement platform for medical supplies, which raised $9.5M to enhance data quality and digitize procurement processes. These investments highlight b2venture's commitment to supporting advancements in healthcare analytics and technology.


10. IBB Ventures


IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in early-stage financing and has invested in over 270 startups, providing not only capital but also expertise and resources to help these businesses thrive. In 2024, IBB Ventures has been particularly active, participating in 18 investments. Notably, they have invested in Aignostics, a Berlin-based biotech startup that raised €14 million in a Series A round to advance its AI platform for diagnostics, and later raised $34 million in a Series B round. They also supported x-cardiac, which focuses on cardiac health solutions, indicating their commitment to healthcare innovation and analytics. These transactions highlight IBB Ventures' strategic focus on the healthcare sector, particularly in analytics-driven startups.


11. Debiopharm


Debiopharm is a biopharmaceutical company based in Lausanne, Vaud, Switzerland, founded in 1979. The company specializes in the development and manufacturing of innovative therapies for cancer and infectious diseases, partnering with academic and pharmaceutical institutions to bridge the gap between drug discovery and patient access. In addition to their core focus on biopharmaceuticals, Debiopharm has made significant investments in healthcare analytics. They participated in the Series C funding rounds for Carevive Systems, which offers a software and analytics platform aimed at improving clinical decision-making and patient care. Furthermore, Debiopharm invested in BC Platforms, a company specializing in genomic data management and analytics, which is essential for advancing personalized medicine. Their recent investment in Altis Labs, which utilizes AI imaging biomarker technology for clinical trials, further underscores their commitment to supporting innovative analytics solutions in healthcare.


12. Earlybird Venture Capital


Earlybird Venture Capital is a venture capital firm founded in 1997, based in Germany, that specializes in investing in European technology innovators. With a focus on nurturing early-stage companies, Earlybird provides financial resources and strategic support, particularly in the digital health and deep tech sectors. Notable transactions include their investment in Noscendo, a diagnostics company that closed a Series A funding round in 2020, and Sense Biodetection, which raised significant funding for its molecular diagnostics technology aimed at infectious diseases. These investments highlight Earlybird's commitment to advancing healthcare technologies, including analytics solutions that can enhance diagnostics and patient care.


13. Wellington Partners


Wellington Partners is a venture capital firm based in Munich, Bavaria, Germany, specializing in life sciences. Founded in 1998, the firm focuses on early- and growth-stage companies, providing both capital and strategic support to entrepreneurs in sectors such as therapeutics and medical devices. Notably, Wellington Partners has been involved in several key transactions in the healthcare analytics domain. They led a €14 million Series A investment in Aignostics, a biotech startup that utilizes AI for healthcare applications, and participated in a $55 million Series B round for Sidekick Health, a company dedicated to digital therapeutics. Additionally, they co-led a €4.5 million Seed Round for nyra health, which aims to enhance AI technology in healthcare. These transactions highlight Wellington Partners' commitment to fostering innovation in healthcare analytics and related fields.


14. Leaps by Bayer

  • Website: leaps.bayer.com
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2015
  • Headcount: 11-50
  • Number of deals in 2024: 16
  • LinkedIn: leapsbybayer

Leaps by Bayer is a venture capital investment firm based in Berlin, Germany, founded in 2015. The firm focuses on biotechnology and agriculture, investing in early-stage companies that pursue scientific breakthroughs to tackle significant global challenges in health and food security. Leaps by Bayer provides funding and active incubation to support the development of innovative solutions in these sectors. Notably, they have made significant investments in healthcare analytics-related companies, including Huma, which raised $130 million to scale its digital health platform, and Ada Health, which raised over $90 million to enhance its health assessment technology. Additionally, their investment in Woebot Health, a company developing digital therapeutics for mental health, showcases their commitment to advancing healthcare analytics and digital health solutions.


15. Boehringer Ingelheim Venture Fund

  • Website: boehringer-ingelheim-venture.com
  • Type: Venture Capital
  • Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 5

Boehringer Ingelheim Venture Fund is a venture capital firm founded in 2010, based in Ingelheim Am Rhein, Germany. The fund focuses on investing in pioneering science and biotechnology innovations, particularly in the healthcare sector. It supports startups in areas such as immuno-oncology and digital health, providing both capital and expertise to help them develop and commercialize their products. Notably, the fund has been involved in several significant transactions relevant to healthcare analytics. For instance, it led a $12.69 million Series A funding round for xCures, which is developing an AI-powered platform for precision oncology decision-making. Additionally, it has co-led multiple funding rounds for Brainomix, a company that is enhancing its AI-enabled platform for imaging biomarkers, which are crucial for better treatment outcomes in various diseases, including lung fibrosis and cancer. These investments highlight the fund's commitment to advancing healthcare analytics through innovative technology.


16. Point Nine

  • Website: pointnine.com
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2011
  • Headcount: 11-50
  • Number of deals in 2024: 16
  • LinkedIn: point-nine-capital

Point Nine is a venture capital firm based in Berlin, Germany, founded in 2011. The firm specializes in investing in early-stage companies, particularly in the SaaS, enterprise software, and B2B marketplace sectors. They provide funding at the seed stage and are committed to participating in subsequent funding rounds to help startups scale their operations. Notably, Point Nine has invested in healthcare-related companies such as Zentist, which raised $8 million in Series A funding in 2019 and focuses on dental care management, and DocPlanner, which has raised multiple rounds of funding (including $10 million in Series B in 2015) and operates a platform for booking medical appointments. These transactions highlight Point Nine's engagement in the healthcare sector, particularly in technology solutions that enhance healthcare delivery and analytics.



Healthcare Analytics Insights: Key Investors in DACH


InvestorHeadquarterSizeFoundedDeals 2024
SpeedinvestVienna, Vienna, Austria51-200201145
NovartisBasel, Basel, Switzerland10001+19967
Bayern KapitalLandshut, Bavaria, Germany11-50199527
Novartis Venture FundBasel, Basel, Switzerland11-50199610
SicticZurich, Zurich, Switzerland201-500201477
Verve VenturesZurich, Zurich, Switzerland11-50201025
Calm/StormVienna, Vienna, Austria1-10202013
HBM Healthcare Investments AGZug, Zug, Switzerland1001-500020018
b2ventureSt. Gallen, St. Gallen, Switzerland11-50200015
IBB VenturesBerlin, Berlin, Germany11-50199718
DebiopharmLausanne, Vaud, Switzerland201-50019794
Earlybird Venture CapitalGermany51-200199729
Wellington PartnersMunich, Bavaria, Germany11-5019989
Leaps by BayerBerlin, Berlin, Germany11-50201516
Boehringer Ingelheim Venture FundIngelheim Am Rhein, Rhineland-Palatinate, Germany11-5020105
Point NineBerlin, Berlin, Germany11-50201116


Want to find more investors focusing on the healthcare analytics industry?

If you want to find more investors that are active in the healthcare analyticsindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!